SANUWAVE Health Inc (SNWV): Enterprise Value to EBITDA Ratio

Graphic logo of sanuwave.com (SNWV)

Sanuwave Health Inc (SNWV) business development relies on the confirmed efficacy of wave systems in diabetic wound therapy, the implementation of insurance reimbursements, and the expansion of distribution networks. This chart of the stock price with the 0.00 indicator illustrates the market valuation of the asset. Sanuwave Health Inc (SNWV) is expanding its patient reach through partnerships with trauma centers and medical equipment providers, integrating advanced tissue regeneration methods into clinical practice.

SANUWAVE Health - SNWV Total Company Value to Operating Income Before Depreciation Ratio (period 11/23/2025 - 11/14/2026)

Comprehensive metric breakdowns and analytics for sanuwave.com (SNWV)

- stock price and consensus target price:
Stock Quotes SANUWAVE Health, Inc.|SNWV - Analyst Consensus Forecast
- stock exchange capitalization data:
Market Valuation SANUWAVE Health Inc|SNWV - Aggregate Business Value
- business book valuation details:
Book Value per Share SANUWAVE|SNWV - Book Valuation of Business|Market Capitalization to Book Value Ratio sanuwave.com|SNWV - Cumulative Company Assets
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Sanuwave Health Inc|SNWV - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity SANUWAVE|SNWV - Company Total Debt|Debts to Book Capitalization SANUWAVE Health Inc|SNWV - Long-Term Debt|Company Short-Term Debts SANUWAVE|Quick Ratio sanuwave.com
- financial results and valuation multiples details:
SNWV - Net Financial Result|Projected Future Earnings Sanuwave Health Inc|SNWV - Price to Earnings Ratio|Forward P/E Multiple Sanuwave Health Inc|SNWV - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SANUWAVE Health Inc|SNWV - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months SANUWAVE|SNWV - Earnings per share for the trailing year|Quarterly EPS earnings growth sanuwave.com|SNWV - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Sanuwave Health Inc
- sales volume and revenue indicators:
SNWV - Company Total Sales Volume|Company Future Sales Volume SANUWAVE Health, Inc.|SNWV - P/S Multiple|Forward P/S Multiple SANUWAVE Health Inc
Analysis of all company metrics:SANUWAVE Health, Inc. SNWV
Manufactured products of SANUWAVE

The EV/EBITDA multiple determines the total value of a business relative to its operating profit before depreciation, taxes, and interest. The calculation combines market capitalization and net debt, allowing for an assessment of the real value of assets regardless of the financing structure. By analyzing the EV/EBITDA trajectory, an investor identifies phases of capital overvaluation or undervaluation. For Sanuwave Health Inc (SNWV), this is critical when assessing the commercialization of the patented dermaPACE technology within the tissue regeneration segment.

Competitor analysis

Dexcom Corp - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Penumbra Medical PEN|NOVT: Enterprise Value to EBITDA Ratio|haemonetics.com - Enterprise Value to Operating Income Before Depreciation Ratio|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (CONMED Corp.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulse Medical (PLSE)|Enterprise Value to EBITDA Ratio INMD (InMode Ltd.)|PMI (picardmedical.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surmodics SRDX|SENS - Enterprise Value to EBITDA Ratio|NeuroPace Corp - EV/EBITDA Multiple|Company Value to EBITDA Tactile Systems Technology|OM: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation ELMD|LNSR (LENSAR) - EV/EBITDA Multiple|AVITA Medical Inc. (RCEL) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple PROF|Enterprise Value to EBITDA Ratio bairdmed.com BDMD|EV/EBITDA Multiple EDAP (EDAP TMS)|EV/EBITDA Multiple Apyx Medical Corp APYX|ICCM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TELA (telabio.com) - Enterprise Value to EBITDA Ratio|CytoSorbents Corporation - Business Value to Operating Income Before Depreciation|SRTS (Sensus Healthcare, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA zynex.com ZYXI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization electroCore, Inc. (ECOR)|vicarioussurgical.com (RBOT) - Enterprise Value to EBITDA Multiple|Inspira Technologies - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple SeaStar Medical Holding Corp. ICU|IRIDEX Corp. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Intelligent Bio Solutions INBS|beyondair.net (XAIR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio PFSA (Profusa Inc.)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization STRATA Skin Sciences Inc.|Enterprise Value to EBITDA Ratio GlucoTrack Inc. (GCTK)|EV/EBITDA Multiple NAOV|VERO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger Inc - Enterprise Value to Operating Income Before Depreciation Ratio|BioSig Technologies, Inc. (BSGM) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CUTR - Total Company Value to Operating Income Before Depreciation Ratio|KNW (Know Labs) - EV/EBITDA Multiple|EV/EBITDA Multiple Inari Medical Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nevro Corporation (NVRO)|reshapelifesciences.com - Enterprise Value to Operating Income Before Depreciation|Silk Road Medical, Inc - Enterprise Value to EBITDA Ratio